Jgp Global Gestao De Recursos Ltda. Bei Gene, Ltd. Transaction History
Jgp Global Gestao De Recursos Ltda.
- $126 Million
- Q1 2025
A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 11,995 shares of BGNE stock, worth $2.72 Million. This represents 2.15% of its overall portfolio holdings.
Number of Shares
11,995
Previous 9,374
27.96%
Holding current value
$2.72 Million
Previous $1.73 Million
57.08%
% of portfolio
2.15%
Previous 3.94%
Shares
23 transactions
Others Institutions Holding BGNE
# of Institutions
295Shares Held
40.1MCall Options Held
111KPut Options Held
114K-
Baker Bros. Advisors LP New York, NY8.8MShares$1.99 Billion23.78% of portfolio
-
Capital International Investors Los Angeles, CA5.09MShares$1.15 Billion0.24% of portfolio
-
Primecap Management CO Pasadena, CA5.06MShares$1.15 Billion0.97% of portfolio
-
Baillie Gifford & CO3.63MShares$823 Million0.74% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.71MShares$615 Million0.09% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...